Solid lipid nanoparticles: production, characterization and applications.

By W. Mehnert, K. Mäder. Advanced Drug Delivery Reviews, 2001

3,056 citations recorded by the source corpus.

Subfields: Molecular Biology, Organic Chemistry, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/066a12b69280f53cc074d13ac47ab1d369fbcde8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. M. Üner
2. G. Yener
3. J. Benoit
4. P. Saulnier
5. W. Charman
6. Colin W. Pouton
7. Christopher J. H. Porter
8. S. Charman

In Organic Chemistry

1. J. Benoit
2. Phatsapong Yingchoncharoen
3. M. Üner
4. A. De
5. Ajeet Kumar
6. E. B. Souto
7. C. M. Barbosa
8. P. Saulnier

In Pharmaceutical Science

1. M. Üner
2. G. Yener
3. Christopher J. H. Porter
4. W. Charman
5. Natalie L. Trevaskis
6. R. Shanker
7. S. Charman
8. H. Williams

Citations in the corpus

• Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability (2014, background): “Mehnert and Mader, in their review, have described several advantages as well as disadvantages of SLN technology [81].”
• Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives (2007, background): “All rights reserved International Journal of Nanomedicine 2007:2(3) 289–300 289 Melike Üner Gülgün Yener 1Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Beyazit 34119 Istanbul, Turkey Correspondence: Melike Üner Istanbul University, Faculty of Pharmacy,…”
• Targeted Delivery of Pesticides Using Biodegradable Polymeric Nanoparticles (2013, background): “However, the polymorphism of these lipid matrixes and possible crystal rearrangements has to be controlled to avoid stability problems in these structures (gelification problems) (Mehnert and Mäder 2001).”
• Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors (2017, background): “10,11 Various models have been proposed to incorporate drugs into SLNs. Depending upon the composition of SLNs (lipid, drug and surfactant) and production conditions (hot or cold homogenization), drug can either be dispersed homogeneously in lipid matrix (solid solution/homogeneous matrix model) of…”
• Physico-chemical stability of colloidal lipid particles. (2003, background): “A recent review on SLN has largely described the origin and the consequences of SLN dispersion gelling [15].”